CTI BIOPHARMA CORP's ticker is CTIC and the CUSIP is 12648L601. A total of 64 filers reported holding CTI BIOPHARMA CORP in Q4 2021. The put-call ratio across all filers is 0.87 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $8,205,590 | -21.9% | 1,953,712 | +11.8% | 0.08% | -9.2% |
| Q4 2022 | $10,503,076 | +35.7% | 1,747,600 | +31.5% | 0.09% | +33.8% |
| Q3 2022 | $7,738,000 | +52.9% | 1,329,476 | +56.8% | 0.06% | +32.7% |
| Q2 2022 | $5,060,000 | +417.4% | 847,700 | +304.4% | 0.05% | +444.4% |
| Q1 2022 | $978,000 | +130.7% | 209,600 | +22.4% | 0.01% | +125.0% |
| Q4 2021 | $424,000 | +89.3% | 171,200 | +125.3% | 0.00% | +100.0% |
| Q3 2021 | $224,000 | +16.1% | 76,000 | -1.3% | 0.00% | 0.0% |
| Q2 2021 | $193,000 | +65.0% | 77,000 | +90.0% | 0.00% | +100.0% |
| Q1 2021 | $117,000 | -19.3% | 40,526 | -10.1% | 0.00% | -50.0% |
| Q4 2020 | $145,000 | – | 45,100 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|